Literature DB >> 22201888

Activation of Wnt and Myc signaling in hepatoblastoma.

Stefano Cairo1, Carolina Armengol, Marie Annick Buendia.   

Abstract

Hepatoblastoma (HB) is the most common type of pediatric liver cancer. This tumor is thought to derive from hepatic progenitor cells that are arrested at various stages of liver development, as illustrated by a variety of histologic subtypes. Recent genomic studies have led to better understand the molecular pathogenesis of HB, to point out the crucial roles of the Wnt Myc signaling pathways in malignant transformation of liver progenitor cells. Molecular classification of HB based on genome-wide studies, as well as identification of reliable diagnostic prognostic markers, open the way to the development of new personalized targeted therapies for the management of aggressive lethal childhood tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201888     DOI: 10.2741/393

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  12 in total

1.  Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.

Authors:  Huabo Wang; Jie Lu; Lia R Edmunds; Sucheta Kulkarni; James Dolezal; Junyan Tao; Sarangarajan Ranganathan; Laura Jackson; Marc Fromherz; Donna Beer-Stolz; Radha Uppala; Sivakama Bharathi; Satdarshan P Monga; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

2.  Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.

Authors:  Laura Molina; Danielle Bell; Junyan Tao; Morgan Preziosi; Tirthadipa Pradhan-Sundd; Sucha Singh; Minakshi Poddar; Jianhua Luo; Sarangarajan Ranganathan; Maria Chikina; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2018-06-18       Impact factor: 4.307

3.  Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage.

Authors:  Agnès Garnier; Matthias Ilmer; Kristina Becker; Beate Häberle; Dietrich VON Schweinitz; Roland Kappler; Michael Berger
Journal:  Oncol Lett       Date:  2015-11-20       Impact factor: 2.967

4.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

5.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

6.  MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.

Authors:  Hua Liu; Xuan-Fu Xu; Yan Zhao; Mao-Chun Tang; Ying-Qun Zhou; Jie Lu; Feng-Hou Gao
Journal:  Tumour Biol       Date:  2014-08-29

Review 7.  Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.

Authors:  Edward V Prochownik
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

8.  Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo.

Authors:  Emilie Indersie; Katarzyna B Hooks; Caroline Capdevielle; Monique Fabre; Nathalie Dugot-Senant; Angélique Desplat; Sébastien Lepreux; Aksam Merched; Christophe F Grosset; Martin Hagedorn
Journal:  Oncotarget       Date:  2018-03-01

Review 9.  The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.

Authors:  Eric S Goetzman; Edward V Prochownik
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-12       Impact factor: 5.555

Review 10.  Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.

Authors:  Ying-Li Sha; Shuang Liu; Wen-Wen Yan; Bo Dong
Journal:  Biosci Rep       Date:  2019-09-24       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.